Gnome Sciences Announces Promising ALS Research Gnome Sciences, a leader in molecular pathology and translational research, has announced encouraging results from a newly published study investigating the potential of a cancer drug in treating amyotrophic lateral sclerosis (ALS). The announcement, made in Columbus, Ohio, underscores a growing interest in repurposing oncology therapies to address complex…